Cover Image
Market Research Report
Product code
994032

Allogeneic Stem Cells

Published: | Global Industry Analysts, Inc. | 171 Pages | Delivery time: 1-2 business days

Price

Back to Top
Allogeneic Stem Cells
Published: April 1, 2021
Global Industry Analysts, Inc.
Content info: 171 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Abstract:

Global Allogeneic Stem Cells Market to Reach $1.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Allogeneic Stem Cells estimated at US$666.3 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at aCAGR of 10.6% over the period 2020-2027. Regenerative Therapy, one of the segments analyzed in the report, is projected to record 11.5% CAGR and reach US$869.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Discovery & Development segment is readjusted to a revised 9.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $179.9 Million, While China is Forecast to Grow at 14.2% CAGR

The Allogeneic Stem Cells market in the U.S. is estimated at US$179.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$292.7 Million by the year 2027 trailing a CAGR of 14.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 9.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Select Competitors (Total 33 Featured) -

  • Biosolution Co. Ltd.
  • Cynata Therapeutics Ltd.
  • JCR Pharmaceuticals Co. Ltd.
  • Lineage Cell Therapeutics Inc.
  • MEDIPOST Co. Ltd.
  • MiMedx Group Inc.
  • Osiris Therapeutics Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.;
Table of Contents
Product Code: MCP17192

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Regenerative Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Regenerative Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Regenerative Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 10: USA Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 11: USA Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: USA 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 13: Canada Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 14: Canada Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: Canada 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 16: Japan Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 17: Japan Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: Japan 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 19: China Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 20: China Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: China 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 22: Europe Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: Europe Historic Review for Allogeneic Stem Cells by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: Europe 15-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 25: Europe Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Europe Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: Europe 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 28: France Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: France Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: France 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 31: Germany Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Germany Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: Germany 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 34: Italy Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Italy Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: Italy 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 37: UK Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: UK Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: UK 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 40: Spain Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Spain Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Spain 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 43: Russia Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Russia Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Russia 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 46: Rest of Europe Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Rest of Europe Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Rest of Europe 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 49: Asia-Pacific Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 50: Asia-Pacific Historic Review for Allogeneic Stem Cells by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Asia-Pacific 15-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 52: Asia-Pacific Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Asia-Pacific Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Asia-Pacific 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 55: Australia Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Australia Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Australia 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 58: India Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: India Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: India 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 61: South Korea Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: South Korea Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: South Korea 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 64: Rest of Asia-Pacific Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Rest of Asia-Pacific Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Rest of Asia-Pacific 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 67: Latin America Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 68: Latin America Historic Review for Allogeneic Stem Cells by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Latin America 15-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 70: Latin America Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Latin America Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Latin America 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 73: Argentina Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Argentina Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Argentina 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 76: Brazil Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Brazil Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Brazil 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 79: Mexico Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Mexico Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: Mexico 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 82: Rest of Latin America Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Rest of Latin America Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: Rest of Latin America 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 85: Middle East Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 86: Middle East Historic Review for Allogeneic Stem Cells by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Middle East 15-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 88: Middle East Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Middle East Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Middle East 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 91: Iran Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Iran Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Iran 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 94: Israel Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Israel Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Israel 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 97: Saudi Arabia Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Saudi Arabia Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Saudi Arabia 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 100: UAE Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: UAE Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: UAE 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 103: Rest of Middle East Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Rest of Middle East Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Rest of Middle East 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 106: Africa Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Africa Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Africa 15-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 33